Showing results (721-730 of 2,319) with videos related to
Sort By:
Pageof 232
Expert Opinion on Therapeutic Targets|May 8, 2010
Gap junctions and connexins as therapeutic targets in cancerMustapha Kandouz, Gerald BatistExpert Opinion on Therapeutic Targets|May 22, 2009
Excitatory amino acid transporters as potential drug targetsLennart Bunch, Mette N Erichsen, Anders A JensenExpert Opinion on Therapeutic Targets|May 5, 2009
Targeting the eicosanoid pathway in non-small-cell lung cancerLeora Horn, Michael Backlund, David H JohnsonExpert Opinion on Therapeutic Targets|December 10, 2008
Serum total homocysteine, folate, 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C-->T genotype and subclinical atherosclerosisAndrie Panayiotou, Andrew Nicolaides, Maura Griffin, et al.Expert Opinion on Therapeutic Targets|December 10, 2008
Defining protein interactions that regulate disease progressionRacha Al-Khoury, Benoit CoulombeExpert Opinion on Therapeutic Targets|December 10, 2008
Vitamin D and the vasculature: can we teach an old drug new tricks?José M Valdivielso, Blai Coll, Elvira FernandezExpert Opinion on Therapeutic Targets|December 10, 2008
The angiopoietin-Tie2 system as a therapeutic target in sepsis and acute lung injuryMelanie van der Heijden, Geerten P van Nieuw Amerongen, Sunita Chedamni, et al.Expert Opinion on Therapeutic Targets|December 10, 2008
Melanoma: targeting signaling pathways and RaLPLuigi Pasini, Margherita Y Turco, Lucilla Luzi, et al.Expert Opinion on Therapeutic Targets|February 25, 2009
HSP 70 and atherosclerosis--protector or activator?Agata Bielecka-Dabrowa, Marcin Barylski, Dimitri P Mikhailidis, et al.Expert Opinion on Therapeutic Targets|February 25, 2009
The transcription factor Nrf2 as a new therapeutic target in Parkinson's diseaseAntonio Cuadrado, Paz Moreno-Murciano, José Pedraza-ChaverriPageof 232